{
    "title": "GlaxoSmithKline agrees \u00a3209m deal with Adaptimmune to develop army of cancer cell therapies",
    "url": "https://www.dailymail.co.uk/money/markets/article-2646126/GlaxoSmithKline-agrees-209m-deal-Adaptimmune-develop-army-cancer-cell-therapies.html",
    "date": "2014-06-02",
    "keywords": [
        "cancer",
        "deal",
        "glaxosmithkline",
        "gsk",
        "adaptimmune",
        "cell",
        "news",
        "company",
        "development",
        "market",
        "rival",
        "novartis",
        "consumer",
        "healthcare",
        "takeover",
        "equity",
        "series",
        "companys",
        "week",
        "astrazeneca",
        "army",
        "west",
        "gmt",
        "june",
        "email",
        "view",
        "therapiesadaptimmune",
        "program",
        "statesthe",
        "tieup",
        "subject",
        "commercialisation",
        "fight",
        "strike",
        "division",
        "boost",
        "aftermath",
        "bid",
        "type",
        "blood",
        "cellsit",
        "matter",
        "threepart",
        "pair",
        "groupgsk",
        "unit",
        "business",
        "return",
        "capital",
        "effort",
        "transaction",
        "host",
        "portfolio",
        "order",
        "investment",
        "productsbuyout",
        "blackstone",
        "kkr",
        "advent",
        "list",
        "relief",
        "stock",
        "value",
        "investigation",
        "chinathe",
        "fraud",
        "office",
        "reference",
        "group",
        "china",
        "drug",
        "pfizer",
        "firmover",
        "weekend",
        "treatment",
        "hope",
        "battle",
        "lung",
        "cent",
        "casesand",
        "study",
        "combination",
        "length",
        "time",
        "disease"
    ],
    "category": [
        "money",
        "markets"
    ]
}